Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Debernardis

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Anti-Cancer Drugs|July 1, 1996
Interactions between taxol and camptothecinD Debernardis, G Cimoli, S Parodi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracilC Aschele, D Debernardis, G Tunesi, et al.
International Journal of Oncology|May 10, 2011
Tumor-necrosis-factor and DNA topoisomerase-ii inhibitors in human ovarian-cancer - potential role in chemotherapyM Aluigi, D Debernardis, G Cimoli, et al.
Cell and Tissue Research|February 1, 1996
NADPH diaphorase activity around the suprachiasmatic nucleus in rat brainD Lupi, D Debernardis, S Vallerga, et al.
Mutation Research|November 1, 1995
Interferon-alpha or beta potentiate platinum analogous in human glioblastoma cell linesS Stanzione, G Cimoli, D Debernardis, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1996
Endogenous tumor necrosis factor enhances topoisomerase II inhibitors activity in human ovarian cancer cell linesD Debernardis, S Stanzione, C Ottoboni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Schedule-dependent synergism between raltitrexed and irinotecan in human colon cancer cells in vitroC Aschele, C Baldo, A F Sobrero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapyC Aschele, D Debernardis, S Casazza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cellsA Guglielmi, C Aschele, A Mori, et al.
Cancer Research|March 1, 1997
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxelD Debernardis, E G Siré, P De Feudis, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Anti-Cancer Drugs|July 1, 1996
Interactions between taxol and camptothecinD Debernardis, G Cimoli, S Parodi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracilC Aschele, D Debernardis, G Tunesi, et al.
International Journal of Oncology|May 10, 2011
Tumor-necrosis-factor and DNA topoisomerase-ii inhibitors in human ovarian-cancer - potential role in chemotherapyM Aluigi, D Debernardis, G Cimoli, et al.
Cell and Tissue Research|February 1, 1996
NADPH diaphorase activity around the suprachiasmatic nucleus in rat brainD Lupi, D Debernardis, S Vallerga, et al.
Mutation Research|November 1, 1995
Interferon-alpha or beta potentiate platinum analogous in human glioblastoma cell linesS Stanzione, G Cimoli, D Debernardis, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1996
Endogenous tumor necrosis factor enhances topoisomerase II inhibitors activity in human ovarian cancer cell linesD Debernardis, S Stanzione, C Ottoboni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Schedule-dependent synergism between raltitrexed and irinotecan in human colon cancer cells in vitroC Aschele, C Baldo, A F Sobrero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapyC Aschele, D Debernardis, S Casazza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cellsA Guglielmi, C Aschele, A Mori, et al.
Cancer Research|March 1, 1997
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxelD Debernardis, E G Siré, P De Feudis, et al.
Pageof 2